| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.5M | -28.5% |
| R&D Expense | $19.8M | +322.9% |
| SG&A Expense | $6.9M | -63.1% |
| Operating Income | -$24.2M | -21.9% |
| Interest Expense | $110K | -91.5% |
| Net Income | -$24.2M | +16.9% |
| EPS (Basic) | -$11.62 | -685.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.1M | -74.3% |
| Current Assets | $5.3M | -66.2% |
| Total Assets | $5.9M | -64.2% |
| Current Liabilities | $9.5M | -42.6% |
| Total Liabilities | $9.9M | -59.7% |
| Stockholders' Equity | -$3.7M | +52.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.9M | -117.0% |
| Investing Cash Flow | $5K | — |
| Financing Cash Flow | $8.8M | -56.8% |